Wittels et al., 1964 - Google Patents

Biochemical lesion of diphtheria toxin in the heart

Wittels et al., 1964

Document ID: 13337862107857082678
Author: Wittels B; Bressler R; et al.
Publication year: 1964
Publication venue: The Journal of Clinical Investigation

External Links

Cited by

Snippet

Methods White, male guinea pigs weighing 250 to 300 g were used. A standard diet consisting of 50% Purina rabbit chow and 50% oats supplemented with fresh cabbage was used except as indicated. The experimental ani-mals were divided into 4 groups as follows …

Continue reading at www.jci.org (PDF) (other versions)

102000016607 Diphtheria Toxin 0 title abstract description 25

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Similar Documents

Publication	Publication Date	Title
Wittels et al.	1964	Biochemical lesion of diphtheria toxin in the heart
Hennig et al.	1984	Exposure to free fatty acid increases the transfer of albumin across cultured endothelial monolayers.
Traber et al.	1985	Bovine milk lipoprotein lipase transfers tocopherol to human fibroblasts during triglyceride hydrolysis in vitro.
Traber et al.	1984	Vitamin E is delivered to cells via the high affinity receptor for low-density lipoprotein
Durrington et al.	1982	Effects of insulin and glucose on very low density lipoprotein triglyceride secretion by cultured rat hepatocytes
Slack et al.	1962	Lipoprotein lipase in cystic fibrosis of the pancreas
Kelly et al.	1979	Effects of arachidonic acid and other unsaturated fatty acids on mitogenesis in human lymphocytes
Fisher et al.	1981	Muscarinic receptors in chromaffin cell cultures mediate enhanced phospholipid labeling but not catecholamine secretion
Nazzaro-Porro	1987	Azelaic acid
Chait et al.	1979	Low-density lipoprotein receptor activity in cultured human skin fibroblasts. Mechanism of insulin-induced stimulation.
Dowsett et al.	1976	Human breast tumour-induced osteolysis and prostaglandins
Baum et al.	1990	1, 2-Dimethylhydrazine-induced alterations in protein kinase C activity in the rat preneoplastic colon
Berglund et al.	1988	Sn‐protoporphyrin lowers serum bilirubin levels, decreases biliary bilirubin output, enhances biliary heme excretion and potently inhibits hepatic heme oxygenase activity in normal human subjects
Ganguly et al.	1986	Calcium pump activity of sarcoplasmic reticulum in diabetic rat skeletal muscle
Tomford et al.	1981	Effect of thyroparathyroidectomy and parathyroidectomy on renal function and the nephrotic syndrome in rat nephrotoxic serum nephritis
Lubin et al.	1972	Changes in fatty acid metabolism after erythrocyte peroxidation: stimulation of a membrane repair process
Newman et al.	1966	In vitro phospholipid synthesis in normal and atheromatous rabbit aortas
Smith et al.	1990	Hepatic acyl-coenzyme A: cholesterol acyltransferase activity is decreased in patients with cholesterol gallstones.
Chatterjee et al.	1976	Alterations in cell surface glycosphingolipids and other lipid classes of fibroblasts in familial hypercholesterolemia.
Nyberg et al.	1977	Human Adipose Tissue in Culture-VII. The Long-Term Effect of Growth Hormone
Felts et al.	1971	The metabolism of free fatty acids and chylomicron triglyceride fatty acids by isolated rat liver cells
Levy et al.	1990	Effects of food restriction and insulin treatment on (Ca2++ Mg2+)-ATPase response to insulin in kidney basolateral membranes of noninsulin-dependent diabetic rats
Betteridge et al.	1978	Compactin inhibits cholesterol synthesis in lymphocytes and intestinal mucosa from patients with familial hypercholesterolaemia
Grynberg et al.	1988	Activities of some enzymes of phospholipid metabolism in cultured rat ventricular myocytes in normoxic and hypoxic conditions
Orekhov et al.	1986	“Regression” of atherosclerosis in cell culture: effects of stable prostacyclin analogues